NO973001L - Pyrimidin-derivater - Google Patents
Pyrimidin-derivaterInfo
- Publication number
- NO973001L NO973001L NO973001A NO973001A NO973001L NO 973001 L NO973001 L NO 973001L NO 973001 A NO973001 A NO 973001A NO 973001 A NO973001 A NO 973001A NO 973001 L NO973001 L NO 973001L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- pyrimidinyl
- methoxyphenoxy
- pyrimidinyloxy
- synthesis
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title claims abstract description 28
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title description 4
- 108050009340 Endothelin Proteins 0.000 claims abstract description 22
- 102000002045 Endothelin Human genes 0.000 claims abstract description 22
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 135
- 239000000203 mixture Substances 0.000 claims description 39
- 229940079593 drug Drugs 0.000 claims description 8
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 abstract description 303
- 125000000217 alkyl group Chemical group 0.000 abstract description 27
- 125000003710 aryl alkyl group Chemical group 0.000 abstract description 11
- 125000003118 aryl group Chemical group 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract description 5
- 230000003639 vasoconstrictive effect Effects 0.000 abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 description 124
- 238000003786 synthesis reaction Methods 0.000 description 124
- 238000005160 1H NMR spectroscopy Methods 0.000 description 112
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 94
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 81
- -1 methoxy, ethoxy, n-propoxy, isopropoxy Chemical group 0.000 description 80
- 239000003921 oil Substances 0.000 description 71
- 239000000843 powder Substances 0.000 description 60
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 230000002829 reductive effect Effects 0.000 description 29
- 239000000243 solution Substances 0.000 description 29
- 125000001424 substituent group Chemical group 0.000 description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 20
- 239000002904 solvent Substances 0.000 description 19
- 159000000000 sodium salts Chemical class 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 14
- 229940080818 propionamide Drugs 0.000 description 14
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 13
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 101150084411 crn1 gene Proteins 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 7
- YKOLZVXSPGIIBJ-UHFFFAOYSA-N 2-Isopropylaniline Chemical compound CC(C)C1=CC=CC=C1N YKOLZVXSPGIIBJ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008485 antagonism Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 239000012300 argon atmosphere Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000012746 preparative thin layer chromatography Methods 0.000 description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 4
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 4
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 210000002376 aorta thoracic Anatomy 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- MQYQOVYIJOLTNX-UHFFFAOYSA-N dichloromethane;n,n-dimethylformamide Chemical compound ClCCl.CN(C)C=O MQYQOVYIJOLTNX-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- PXJACNDVRNAFHD-UHFFFAOYSA-N (2-methoxyphenyl)methanamine Chemical compound COC1=CC=CC=C1CN PXJACNDVRNAFHD-UHFFFAOYSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- RZBOMSOHMOVUES-UHFFFAOYSA-N 2-(2-chlorophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1Cl RZBOMSOHMOVUES-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 125000005343 heterocyclic alkyl group Chemical group 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- DGNZGWDLQMQJRJ-UHFFFAOYSA-N n-[2-[4,6-bis(3-hydroxypropoxy)pyrimidin-2-yl]-6-(3-hydroxypropoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=C(OCCCO)C=C(OCCCO)N=2)OCCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 DGNZGWDLQMQJRJ-UHFFFAOYSA-N 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000013014 purified material Substances 0.000 description 3
- CUYKNJBYIJFRCU-UHFFFAOYSA-N pyridine-3-amine Natural products NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- PALBHKATLKQZER-UHFFFAOYSA-N (3-methyloxetan-3-yl)methyl 3-phenylmethoxypropanoate Chemical compound C=1C=CC=CC=1COCCC(=O)OCC1(C)COC1 PALBHKATLKQZER-UHFFFAOYSA-N 0.000 description 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 2
- WMEJFOASTQGIRO-UHFFFAOYSA-N 1-methyl-4-(2-phenylmethoxyethyl)-3,5,8-trioxabicyclo[2.2.2]octane Chemical compound O1CC(C)(CO2)COC21CCOCC1=CC=CC=C1 WMEJFOASTQGIRO-UHFFFAOYSA-N 0.000 description 2
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 2
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 2
- UFFBMTHBGFGIHF-UHFFFAOYSA-N 2,6-dimethylaniline Chemical compound CC1=CC=CC(C)=C1N UFFBMTHBGFGIHF-UHFFFAOYSA-N 0.000 description 2
- AUSGHWJMOCPLII-UHFFFAOYSA-N 2-(1-methyl-3,5,8-trioxabicyclo[2.2.2]octan-4-yl)ethanol Chemical compound C1OC2(CCO)OCC1(C)CO2 AUSGHWJMOCPLII-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- MLPVBIWIRCKMJV-UHFFFAOYSA-N 2-ethylaniline Chemical compound CCC1=CC=CC=C1N MLPVBIWIRCKMJV-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 2
- OZGUGVRKYBSDBN-UHFFFAOYSA-N 3-phenylmethoxypropanoic acid Chemical compound OC(=O)CCOCC1=CC=CC=C1 OZGUGVRKYBSDBN-UHFFFAOYSA-N 0.000 description 2
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 2
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010002388 Angina unstable Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 239000003810 Jones reagent Substances 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- 101710205037 Sarafotoxin Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 2
- 208000007814 Unstable Angina Diseases 0.000 description 2
- 208000012931 Urologic disease Diseases 0.000 description 2
- 206010047163 Vasospasm Diseases 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000037765 diseases and disorders Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 201000004332 intermediate coronary syndrome Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 201000004240 prostatic hypertrophy Diseases 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- NWELCUKYUCBVKK-UHFFFAOYSA-N pyridin-2-ylhydrazine Chemical compound NNC1=CC=CC=N1 NWELCUKYUCBVKK-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 206010038464 renal hypertension Diseases 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- WORJEOGGNQDSOE-ASTXPPQBSA-N trichloro(deuterio)methane;trideuterio(deuteriooxy)methane Chemical compound [2H]C(Cl)(Cl)Cl.[2H]OC([2H])([2H])[2H] WORJEOGGNQDSOE-ASTXPPQBSA-N 0.000 description 2
- 208000014001 urinary system disease Diseases 0.000 description 2
- 231100000216 vascular lesion Toxicity 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 1
- PQCUDKMMPTXMAL-UHFFFAOYSA-N (2,6-difluorophenyl)methanamine Chemical compound NCC1=C(F)C=CC=C1F PQCUDKMMPTXMAL-UHFFFAOYSA-N 0.000 description 1
- CJAAPVQEZPAQNI-UHFFFAOYSA-N (2-methylphenyl)methanamine Chemical compound CC1=CC=CC=C1CN CJAAPVQEZPAQNI-UHFFFAOYSA-N 0.000 description 1
- YUPUSBMJCFBHAP-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)methanamine Chemical compound COC1=CC(CN)=CC(OC)=C1OC YUPUSBMJCFBHAP-UHFFFAOYSA-N 0.000 description 1
- BJFPYGGTDAYECS-UHFFFAOYSA-N (3-chlorophenyl)methanamine Chemical compound NCC1=CC=CC(Cl)=C1 BJFPYGGTDAYECS-UHFFFAOYSA-N 0.000 description 1
- GRRIMVWABNHKBX-UHFFFAOYSA-N (3-methoxyphenyl)methanamine Chemical compound COC1=CC=CC(CN)=C1 GRRIMVWABNHKBX-UHFFFAOYSA-N 0.000 description 1
- PMHUSCHKTSTQEP-UHFFFAOYSA-N (4-carbamimidoylphenyl)methanesulfonyl fluoride Chemical compound NC(=N)C1=CC=C(CS(F)(=O)=O)C=C1 PMHUSCHKTSTQEP-UHFFFAOYSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- ZILSBZLQGRBMOR-UHFFFAOYSA-N 1,3-benzodioxol-5-ylmethanamine Chemical compound NCC1=CC=C2OCOC2=C1 ZILSBZLQGRBMOR-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- FCDWMZXPGPZXFW-UHFFFAOYSA-N 1,5-dihydrotriazol-2-amine Chemical compound NN1NCC=N1 FCDWMZXPGPZXFW-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 description 1
- NAZDVUBIEPVUKE-UHFFFAOYSA-N 2,5-dimethoxyaniline Chemical compound COC1=CC=C(OC)C(N)=C1 NAZDVUBIEPVUKE-UHFFFAOYSA-N 0.000 description 1
- WKBALTUBRZPIPZ-UHFFFAOYSA-N 2,6-di(propan-2-yl)aniline Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N WKBALTUBRZPIPZ-UHFFFAOYSA-N 0.000 description 1
- XNIOWJUQPMKCIJ-UHFFFAOYSA-N 2-(benzylamino)ethanol Chemical compound OCCNCC1=CC=CC=C1 XNIOWJUQPMKCIJ-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- QZPIEOVZJRJBHV-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(1-phenylethyl)acetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NC(C)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QZPIEOVZJRJBHV-UHFFFAOYSA-N 0.000 description 1
- FDRDLAYORLASEX-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-methoxyphenyl)acetamide Chemical compound COC1=CC=CC=C1NC(=O)COC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC FDRDLAYORLASEX-UHFFFAOYSA-N 0.000 description 1
- KUSHPFKBPBODOK-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-phenylethyl)acetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NCCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 KUSHPFKBPBODOK-UHFFFAOYSA-N 0.000 description 1
- ANMGQLIJIJMLPG-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(3-chlorophenyl)acetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NC=2C=C(Cl)C=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ANMGQLIJIJMLPG-UHFFFAOYSA-N 0.000 description 1
- QSMAUKIKPWGXNT-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(3-methylpyridin-2-yl)acetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NC=2C(=CC=CN=2)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QSMAUKIKPWGXNT-UHFFFAOYSA-N 0.000 description 1
- BIKBKRAIMQDXPU-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)COC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC BIKBKRAIMQDXPU-UHFFFAOYSA-N 0.000 description 1
- QKEAHNNTSXTQAO-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-methoxy-n-methylacetamide Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCC(=O)N(C)OC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QKEAHNNTSXTQAO-UHFFFAOYSA-N 0.000 description 1
- GFQOOYRYHYGHNQ-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-phenylacetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GFQOOYRYHYGHNQ-UHFFFAOYSA-N 0.000 description 1
- UUDDVJBVMSDKEZ-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyridin-2-ylacetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 UUDDVJBVMSDKEZ-UHFFFAOYSA-N 0.000 description 1
- NBACWNHGAUEPGH-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxyacetic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 NBACWNHGAUEPGH-UHFFFAOYSA-N 0.000 description 1
- RLFQFYCPQKVOFE-UHFFFAOYSA-N 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenyl)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-methoxy-n-methylacetamide Chemical compound C=1C=CC=C(OC)C=1C=1C(OCC(=O)N(C)OC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 RLFQFYCPQKVOFE-UHFFFAOYSA-N 0.000 description 1
- IJXJGQCXFSSHNL-UHFFFAOYSA-N 2-amino-2-phenylethanol Chemical compound OCC(N)C1=CC=CC=C1 IJXJGQCXFSSHNL-UHFFFAOYSA-N 0.000 description 1
- AKCRQHGQIJBRMN-UHFFFAOYSA-N 2-chloroaniline Chemical compound NC1=CC=CC=C1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 1
- FSJOLBAFVKSQQJ-UHFFFAOYSA-N 2-ethylpyrazol-3-amine Chemical compound CCN1N=CC=C1N FSJOLBAFVKSQQJ-UHFFFAOYSA-N 0.000 description 1
- VXDHQYLFEYUMFY-UHFFFAOYSA-N 2-methylprop-2-en-1-amine Chemical compound CC(=C)CN VXDHQYLFEYUMFY-UHFFFAOYSA-N 0.000 description 1
- WBRPQQSADOCKCH-UHFFFAOYSA-N 2-methylsulfanylaniline Chemical compound CSC1=CC=CC=C1N WBRPQQSADOCKCH-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- HEDYZFYQYPWWCC-UHFFFAOYSA-N 2-prop-1-en-2-ylaniline Chemical compound CC(=C)C1=CC=CC=C1N HEDYZFYQYPWWCC-UHFFFAOYSA-N 0.000 description 1
- XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 1
- AEIOZWYBDBVCGW-UHFFFAOYSA-N 2-tert-butylaniline Chemical compound CC(C)(C)C1=CC=CC=C1N AEIOZWYBDBVCGW-UHFFFAOYSA-N 0.000 description 1
- MWOOKDULMBMMPN-UHFFFAOYSA-N 3-(2-ethyl-1,2-oxazol-2-ium-5-yl)benzenesulfonate Chemical compound O1[N+](CC)=CC=C1C1=CC=CC(S([O-])(=O)=O)=C1 MWOOKDULMBMMPN-UHFFFAOYSA-N 0.000 description 1
- DWPRKILCVRDEOV-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-2-(4,6-dimethylpyrimidin-2-yl)-5-(2-methoxyphenoxy)pyrimidin-4-yl]oxy-n-(2-propan-2-ylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=C(C)C=C(C)N=2)OCCC(=O)NC=2C(=CC=CC=2)C(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 DWPRKILCVRDEOV-UHFFFAOYSA-N 0.000 description 1
- SMFHSZOFKADODZ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-2-(4,6-dimethylpyrimidin-2-yl)-5-(2-methoxyphenoxy)pyrimidin-4-yl]oxy-n-pyridin-2-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=C(C)C=C(C)N=2)OCCC(=O)NC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 SMFHSZOFKADODZ-UHFFFAOYSA-N 0.000 description 1
- JYGXZFYVOAJBBJ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-2-(4,6-dimethylpyrimidin-2-yl)-5-(2-methoxyphenoxy)pyrimidin-4-yl]oxypropanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=C(C)C=C(C)N=2)OCCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JYGXZFYVOAJBBJ-UHFFFAOYSA-N 0.000 description 1
- OTNFMDNPEJICHJ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-2-[4,6-di(propan-2-yloxy)pyrimidin-2-yl]-5-(2-methoxyphenoxy)pyrimidin-4-yl]oxypropanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=C(OC(C)C)C=C(OC(C)C)N=2)OCCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 OTNFMDNPEJICHJ-UHFFFAOYSA-N 0.000 description 1
- CSRMRNNXUCRJGS-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-2,2-dimethylpropanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)(C)C(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 CSRMRNNXUCRJGS-UHFFFAOYSA-N 0.000 description 1
- QULSVPHXOCKFAU-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-2-methyl-n-(2-propan-2-ylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)C(=O)NC=2C(=CC=CC=2)C(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QULSVPHXOCKFAU-UHFFFAOYSA-N 0.000 description 1
- OAOPRZNIXCOOPD-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-2-methyl-n-pyridin-2-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)C(=O)NC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 OAOPRZNIXCOOPD-UHFFFAOYSA-N 0.000 description 1
- WSWMFBPGCJRPNL-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-2-methylpropanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)C(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 WSWMFBPGCJRPNL-UHFFFAOYSA-N 0.000 description 1
- XUAWWKZYIKWRSJ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n,n-dimethylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)N(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 XUAWWKZYIKWRSJ-UHFFFAOYSA-N 0.000 description 1
- YZACDSNEUQGPOB-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(1,3-thiazol-2-yl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2SC=CN=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 YZACDSNEUQGPOB-UHFFFAOYSA-N 0.000 description 1
- OAFBLCJSDKLMDS-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(1-phenylethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC(C)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 OAFBLCJSDKLMDS-UHFFFAOYSA-N 0.000 description 1
- GIIQRKIHGFFIPN-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2,3-dihydro-1h-inden-1-yl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC2C3=CC=CC=C3CC2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GIIQRKIHGFFIPN-UHFFFAOYSA-N 0.000 description 1
- OFATYNGTZFXIHA-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2,5-dimethoxyphenyl)propanamide Chemical compound COC1=CC=C(OC)C(NC(=O)CCOC=2C(=C(NS(=O)(=O)C=3C=CC(=CC=3)C(C)(C)C)N=C(N=2)C=2N=CC=CN=2)OC=2C(=CC=CC=2)OC)=C1 OFATYNGTZFXIHA-UHFFFAOYSA-N 0.000 description 1
- MTNFANNLCUMCNB-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2,6-dimethylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 MTNFANNLCUMCNB-UHFFFAOYSA-N 0.000 description 1
- IBYDQXDFPZXCGR-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-chlorophenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)Cl)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 IBYDQXDFPZXCGR-UHFFFAOYSA-N 0.000 description 1
- AFEDZEWZQYEHNX-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-ethylphenyl)propanamide Chemical compound CCC1=CC=CC=C1NC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC AFEDZEWZQYEHNX-UHFFFAOYSA-N 0.000 description 1
- ZRGWHHYAEVGWNV-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-hydroxy-1-phenylethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC(CO)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZRGWHHYAEVGWNV-UHFFFAOYSA-N 0.000 description 1
- CQUYDFBVVUSQQP-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-hydroxyphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 CQUYDFBVVUSQQP-UHFFFAOYSA-N 0.000 description 1
- HTQFEUFHRRKSLC-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-methoxyphenyl)propanamide Chemical compound COC1=CC=CC=C1NC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC HTQFEUFHRRKSLC-UHFFFAOYSA-N 0.000 description 1
- RMNPOXMXFMHQTG-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-methylsulfanylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)SC)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 RMNPOXMXFMHQTG-UHFFFAOYSA-N 0.000 description 1
- QRRHOHWYMAZEAZ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-nitrophenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)[N+]([O-])=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QRRHOHWYMAZEAZ-UHFFFAOYSA-N 0.000 description 1
- HHGCAZJVZRMKHR-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-phenylethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HHGCAZJVZRMKHR-UHFFFAOYSA-N 0.000 description 1
- ZIBUXGRBAJZDCL-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-prop-1-en-2-ylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)C(C)=C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZIBUXGRBAJZDCL-UHFFFAOYSA-N 0.000 description 1
- CXKUONYFPPNYSU-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-propan-2-ylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)C(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 CXKUONYFPPNYSU-UHFFFAOYSA-N 0.000 description 1
- IIFDONBWJSWSPR-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-pyridin-2-ylethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCCC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 IIFDONBWJSWSPR-UHFFFAOYSA-N 0.000 description 1
- JNKBFUQPZJPIHM-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(3-methylphenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C=C(C)C=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JNKBFUQPZJPIHM-UHFFFAOYSA-N 0.000 description 1
- JBVLPWZMWJTZOP-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(4,5-dihydro-1,3-thiazol-2-yl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2SCCN=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JBVLPWZMWJTZOP-UHFFFAOYSA-N 0.000 description 1
- UJKIYDGBOXQKFZ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(4-chlorophenyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C=CC(Cl)=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 UJKIYDGBOXQKFZ-UHFFFAOYSA-N 0.000 description 1
- DXXSTGHTWITNPO-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(furan-2-ylmethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2OC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 DXXSTGHTWITNPO-UHFFFAOYSA-N 0.000 description 1
- ZACQDJHBRRNXMO-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(pyridin-2-ylmethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZACQDJHBRRNXMO-UHFFFAOYSA-N 0.000 description 1
- ZTDZSYBXTSGDJD-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(thiophen-2-ylmethyl)propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2SC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZTDZSYBXTSGDJD-UHFFFAOYSA-N 0.000 description 1
- HGMWEJYLBVGSER-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(2,4-dimethoxyphenyl)methyl]propanamide Chemical compound COC1=CC(OC)=CC=C1CNC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC HGMWEJYLBVGSER-UHFFFAOYSA-N 0.000 description 1
- PLZQZOGDDOEUBC-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(2,6-difluorophenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C(=CC=CC=2F)F)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 PLZQZOGDDOEUBC-UHFFFAOYSA-N 0.000 description 1
- UNQQHSAWVJVDPW-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(2-methoxyphenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1CNC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC UNQQHSAWVJVDPW-UHFFFAOYSA-N 0.000 description 1
- WUSSURVNMKOIOH-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(2-methylphenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C(=CC=CC=2)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 WUSSURVNMKOIOH-UHFFFAOYSA-N 0.000 description 1
- BGFXUVBKKKHJFR-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(3,4,5-trimethoxyphenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C=C(OC)C(OC)=C(OC)C=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 BGFXUVBKKKHJFR-UHFFFAOYSA-N 0.000 description 1
- WQCAVQDQFIIFCF-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(4-methoxyphenyl)methyl]propanamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC WQCAVQDQFIIFCF-UHFFFAOYSA-N 0.000 description 1
- LUQZKUDUBCXKJP-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(4-nitrophenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C=CC(=CC=2)[N+]([O-])=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 LUQZKUDUBCXKJP-UHFFFAOYSA-N 0.000 description 1
- HOEVESMVBMCFRI-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[2-(2-chlorophenyl)ethyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCCC=2C(=CC=CC=2)Cl)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HOEVESMVBMCFRI-UHFFFAOYSA-N 0.000 description 1
- MZHPJYMTHLSOEQ-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[2-(4-methoxyphenyl)ethyl]propanamide Chemical compound C1=CC(OC)=CC=C1CCNC(=O)CCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC MZHPJYMTHLSOEQ-UHFFFAOYSA-N 0.000 description 1
- ZKONVJKIVUYONE-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2SC(=NN=2)C(F)(F)F)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZKONVJKIVUYONE-UHFFFAOYSA-N 0.000 description 1
- HTHUGTFIRMXDLT-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[[2-(trifluoromethyl)phenyl]methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C(=CC=CC=2)C(F)(F)F)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HTHUGTFIRMXDLT-UHFFFAOYSA-N 0.000 description 1
- OKIOBIJJAMPSAN-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[cyano(phenyl)methyl]propanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC(C#N)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 OKIOBIJJAMPSAN-UHFFFAOYSA-N 0.000 description 1
- FPWPWSUXBSAIML-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-cyclopropylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC2CC2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 FPWPWSUXBSAIML-UHFFFAOYSA-N 0.000 description 1
- QZEWZJFAMPPYRF-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-ethylpropanamide Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)NCC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QZEWZJFAMPPYRF-UHFFFAOYSA-N 0.000 description 1
- YEKYXGASNSJWJX-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-methyl-n-phenylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)N(C)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 YEKYXGASNSJWJX-UHFFFAOYSA-N 0.000 description 1
- HVCNAFMNCLUZMI-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-methylpropanamide Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)NC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HVCNAFMNCLUZMI-UHFFFAOYSA-N 0.000 description 1
- VPQFPYKJFJYFRV-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-naphthalen-1-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C3=CC=CC=C3C=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 VPQFPYKJFJYFRV-UHFFFAOYSA-N 0.000 description 1
- HSBPMZCYOUJCMR-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pentylpropanamide Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)NCCCCC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HSBPMZCYOUJCMR-UHFFFAOYSA-N 0.000 description 1
- AZXRQEKIJYVRJU-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-phenylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 AZXRQEKIJYVRJU-UHFFFAOYSA-N 0.000 description 1
- HZGOTKMKWYXHHM-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyrazin-2-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2N=CC=NC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HZGOTKMKWYXHHM-UHFFFAOYSA-N 0.000 description 1
- ZJEBSQZDRMNUIX-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyridin-2-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZJEBSQZDRMNUIX-UHFFFAOYSA-N 0.000 description 1
- ZITCYFOCNBATAL-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyridin-3-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C=NC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ZITCYFOCNBATAL-UHFFFAOYSA-N 0.000 description 1
- NMXSYNQKNIJGMW-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyrimidin-2-ylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2N=CC=CN=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 NMXSYNQKNIJGMW-UHFFFAOYSA-N 0.000 description 1
- QJSBRAWSQKPCTO-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(N)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QJSBRAWSQKPCTO-UHFFFAOYSA-N 0.000 description 1
- MAJQLYZNBFSSHC-UHFFFAOYSA-N 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 MAJQLYZNBFSSHC-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- RGDQRXPEZUNWHX-UHFFFAOYSA-N 3-methylpyridin-2-amine Chemical compound CC1=CC=CN=C1N RGDQRXPEZUNWHX-UHFFFAOYSA-N 0.000 description 1
- FUCYABRIJPUVAT-UHFFFAOYSA-N 3-phenylmethoxypropan-1-ol Chemical compound OCCCOCC1=CC=CC=C1 FUCYABRIJPUVAT-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- DUWCIRUHTMUHKC-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-methoxyphenyl)butanamide Chemical compound COC1=CC=CC=C1NC(=O)CCCOC1=NC(C=2N=CC=CN=2)=NC(NS(=O)(=O)C=2C=CC(=CC=2)C(C)(C)C)=C1OC1=CC=CC=C1OC DUWCIRUHTMUHKC-UHFFFAOYSA-N 0.000 description 1
- GUGNMVGULAJAQA-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-phenylethyl)butanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(=O)NCCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GUGNMVGULAJAQA-UHFFFAOYSA-N 0.000 description 1
- VYIOJUMANWPIET-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(3-chlorophenyl)butanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(=O)NC=2C=C(Cl)C=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 VYIOJUMANWPIET-UHFFFAOYSA-N 0.000 description 1
- PLQFCBHQZLRPAX-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(3-methoxyphenyl)methyl]butanamide Chemical compound COC1=CC=CC(CNC(=O)CCCOC=2C(=C(NS(=O)(=O)C=3C=CC(=CC=3)C(C)(C)C)N=C(N=2)C=2N=CC=CN=2)OC=2C(=CC=CC=2)OC)=C1 PLQFCBHQZLRPAX-UHFFFAOYSA-N 0.000 description 1
- BGPIPUKONCTKIP-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-phenylbutanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(=O)NC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 BGPIPUKONCTKIP-UHFFFAOYSA-N 0.000 description 1
- MDIDJDDNLJVINK-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-pyridin-2-ylbutanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(=O)NC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 MDIDJDDNLJVINK-UHFFFAOYSA-N 0.000 description 1
- PGRXUPWJTZVRSL-UHFFFAOYSA-N 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxybutanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 PGRXUPWJTZVRSL-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- OZRGLPAXIYOWIG-HZPUXBNGSA-N 4-nitrobenzylamine Chemical compound CC(C)C(CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CCCC[C@]4(C)[C@H]3CC[C@]12C)=O OZRGLPAXIYOWIG-HZPUXBNGSA-N 0.000 description 1
- YQMVZTMTWSYJBA-UHFFFAOYSA-N 4-tert-butyl-N-[6-[4-[2-(2-chlorophenyl)ethylamino]butoxy]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCNCCC=2C(=CC=CC=2)Cl)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 YQMVZTMTWSYJBA-UHFFFAOYSA-N 0.000 description 1
- QSBCKLOQOBCDGT-UHFFFAOYSA-N 4-tert-butyl-n-[2-(4,6-diethoxypyrimidin-2-yl)-6-(3-hydroxypropoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide Chemical compound CCOC1=CC(OCC)=NC(C=2N=C(OCCCO)C(OC=3C(=CC=CC=3)OC)=C(NS(=O)(=O)C=3C=CC(=CC=3)C(C)(C)C)N=2)=N1 QSBCKLOQOBCDGT-UHFFFAOYSA-N 0.000 description 1
- CZLKCTLSPHJJRO-UHFFFAOYSA-N 4-tert-butyl-n-[5-(2-methoxyphenoxy)-6-(2-oxopropoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 CZLKCTLSPHJJRO-UHFFFAOYSA-N 0.000 description 1
- JCCXDNGCRIIPKS-UHFFFAOYSA-N 4-tert-butyl-n-[5-(2-methoxyphenoxy)-6-[2-oxo-2-(2-pyridin-2-ylhydrazinyl)ethoxy]-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NNC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JCCXDNGCRIIPKS-UHFFFAOYSA-N 0.000 description 1
- ANGVHVOZDJRMJI-UHFFFAOYSA-N 4-tert-butyl-n-[5-(2-methoxyphenoxy)-6-[3-oxo-3-(2-phenylhydrazinyl)propoxy]-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NNC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ANGVHVOZDJRMJI-UHFFFAOYSA-N 0.000 description 1
- URBPPFOHMWZICO-UHFFFAOYSA-N 4-tert-butyl-n-[5-(2-methoxyphenoxy)-6-[3-oxo-3-(2-pyridin-2-ylhydrazinyl)propoxy]-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NNC=2N=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 URBPPFOHMWZICO-UHFFFAOYSA-N 0.000 description 1
- ORFCDBCXRCIMGJ-UHFFFAOYSA-N 4-tert-butyl-n-[6-(3-hydroxy-2,2-dimethylpropoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(C)(C)CO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 ORFCDBCXRCIMGJ-UHFFFAOYSA-N 0.000 description 1
- DMRGPFUWWCGAAF-UHFFFAOYSA-N 4-tert-butyl-n-[6-(3-hydroxypropoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 DMRGPFUWWCGAAF-UHFFFAOYSA-N 0.000 description 1
- WWSICQHBLFHSSG-UHFFFAOYSA-N 4-tert-butyl-n-[6-chloro-2-(4,6-dimethoxypyrimidin-2-yl)-5-(2-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC(OC)=NC(C=2N=C(NS(=O)(=O)C=3C=CC(=CC=3)C(C)(C)C)C(OC=3C(=CC=CC=3)OC)=C(Cl)N=2)=N1 WWSICQHBLFHSSG-UHFFFAOYSA-N 0.000 description 1
- XKISWHVJIZSPSC-UHFFFAOYSA-N 4-tert-butyl-n-[6-chloro-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Chemical compound COC1=CC=CC=C1OC1=C(Cl)N=C(C=2N=CC=CN=2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 XKISWHVJIZSPSC-UHFFFAOYSA-N 0.000 description 1
- LTEUXHSAYOSFGQ-UHFFFAOYSA-N 5-(trifluoromethyl)-1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=C(C(F)(F)F)S1 LTEUXHSAYOSFGQ-UHFFFAOYSA-N 0.000 description 1
- YOSHATQQXKGJJS-UHFFFAOYSA-N 5-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-(2-phenylethyl)pentanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCC(=O)NCCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 YOSHATQQXKGJJS-UHFFFAOYSA-N 0.000 description 1
- VCASOCDXFYSDJF-UHFFFAOYSA-N 5-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[(3-chlorophenyl)methyl]pentanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCC(=O)NCC=2C=C(Cl)C=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 VCASOCDXFYSDJF-UHFFFAOYSA-N 0.000 description 1
- GAEVIGZJDMUMNV-UHFFFAOYSA-N 5-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-[2-(2-chlorophenyl)ethyl]pentanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCC(=O)NCCC=2C(=CC=CC=2)Cl)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GAEVIGZJDMUMNV-UHFFFAOYSA-N 0.000 description 1
- QNXLTGRODWNPGK-UHFFFAOYSA-N 5-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypentanoic acid Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCC(O)=O)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 QNXLTGRODWNPGK-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- RJSYPKWVIJGNLO-UHFFFAOYSA-N CCOClOC Chemical compound CCOClOC RJSYPKWVIJGNLO-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 101800004490 Endothelin-1 Proteins 0.000 description 1
- 102100033902 Endothelin-1 Human genes 0.000 description 1
- TWLLPUMZVVGILS-UHFFFAOYSA-N Ethyl 2-aminobenzoate Chemical compound CCOC(=O)C1=CC=CC=C1N TWLLPUMZVVGILS-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZSKQIFWUTUZAGF-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1C(F)(F)F ZSKQIFWUTUZAGF-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- URQAMACHHWVNRD-UHFFFAOYSA-O azanium;1-hydroxybenzotriazole Chemical compound [NH4+].C1=CC=C2N(O)N=NC2=C1 URQAMACHHWVNRD-UHFFFAOYSA-O 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- SUYHCQQCHDPTED-UHFFFAOYSA-N benzyl 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoate Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)OCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 SUYHCQQCHDPTED-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 125000004773 chlorofluoromethyl group Chemical group [H]C(F)(Cl)* 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- GSUURBCXNQYTKI-UHFFFAOYSA-N ethyl 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxyacetate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCC(=O)OCC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GSUURBCXNQYTKI-UHFFFAOYSA-N 0.000 description 1
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 1
- MUXLCVREUMRNOM-UHFFFAOYSA-N ethyl 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)OCC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 MUXLCVREUMRNOM-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 125000002425 furfuryl group Chemical group C(C1=CC=CO1)* 0.000 description 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical compound NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- JDRNABLQHCEKPT-UHFFFAOYSA-N hexyl 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)OCCCCCC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JDRNABLQHCEKPT-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- URVTYACWBLQZAC-UHFFFAOYSA-N methyl 2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxyacetate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCC(=O)OC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 URVTYACWBLQZAC-UHFFFAOYSA-N 0.000 description 1
- RBTNLKFKPZPBNW-UHFFFAOYSA-N methyl 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCC(=O)OC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 RBTNLKFKPZPBNW-UHFFFAOYSA-N 0.000 description 1
- LPBOUPZDHIWNPB-UHFFFAOYSA-N methyl 4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxybutanoate Chemical compound C=1C=CC=C(OC)C=1OC=1C(OCCCC(=O)OC)=NC(C=2N=CC=CN=2)=NC=1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 LPBOUPZDHIWNPB-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- GANMANQCUXTVBD-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C=C3OCOC3=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GANMANQCUXTVBD-UHFFFAOYSA-N 0.000 description 1
- KQLDCEAYLZGOAF-UHFFFAOYSA-N n-(2-aminophenyl)-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)N)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 KQLDCEAYLZGOAF-UHFFFAOYSA-N 0.000 description 1
- KMSHNMVSRBKSQB-UHFFFAOYSA-N n-(2-tert-butylphenyl)-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC=2C(=CC=CC=2)C(C)(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 KMSHNMVSRBKSQB-UHFFFAOYSA-N 0.000 description 1
- INTRIKPMXDLZSY-UHFFFAOYSA-N n-[6-(3-hydroxypropoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]-4-propan-2-ylbenzenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCO)=C1NS(=O)(=O)C1=CC=C(C(C)C)C=C1 INTRIKPMXDLZSY-UHFFFAOYSA-N 0.000 description 1
- RYXCWEPCLMLNLL-UHFFFAOYSA-N n-benzhydryl-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NC(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 RYXCWEPCLMLNLL-UHFFFAOYSA-N 0.000 description 1
- HOEHTBJNZCRGRH-UHFFFAOYSA-N n-benzyl-2-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxyacetamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCC(=O)NCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 HOEHTBJNZCRGRH-UHFFFAOYSA-N 0.000 description 1
- JVVLJBAZMFEIEZ-UHFFFAOYSA-N n-benzyl-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxy-n-methylpropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)N(C)CC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JVVLJBAZMFEIEZ-UHFFFAOYSA-N 0.000 description 1
- LKBQUPPGOBWLQY-UHFFFAOYSA-N n-benzyl-3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)NCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 LKBQUPPGOBWLQY-UHFFFAOYSA-N 0.000 description 1
- WWWUNWNLODAFOO-UHFFFAOYSA-N n-benzyl-4-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxybutanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCC(=O)NCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 WWWUNWNLODAFOO-UHFFFAOYSA-N 0.000 description 1
- JGLDHZQLOPMTSO-UHFFFAOYSA-N n-benzyl-5-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypentanamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCCCC(=O)NCC=2C=CC=CC=2)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 JGLDHZQLOPMTSO-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NVSYANRBXPURRQ-UHFFFAOYSA-N naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CN)=CC=CC2=C1 NVSYANRBXPURRQ-UHFFFAOYSA-N 0.000 description 1
- 125000001326 naphthylalkyl group Chemical group 0.000 description 1
- 125000004998 naphthylethyl group Chemical group C1(=CC=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000002734 organomagnesium group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- UKFLLQIRBABMKF-UHFFFAOYSA-N p-Ethoxybenzyl alcohol Natural products CCOC1=CC=C(CO)C=C1 UKFLLQIRBABMKF-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HPOKESDSMZRZLC-UHFFFAOYSA-N propan-2-one;hydrochloride Chemical compound Cl.CC(C)=O HPOKESDSMZRZLC-UHFFFAOYSA-N 0.000 description 1
- BYNQXZYVTKZHFH-UHFFFAOYSA-N propan-2-yl 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]oxypropanoate Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCC(=O)OC(C)C)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 BYNQXZYVTKZHFH-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- LXPHPKVWHQLBBA-UHFFFAOYSA-N sarafotoxin s6c Chemical compound C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C1NC(=O)C(CC=2C=CC=CC=2)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C2CSSCC(C(NC(CC(N)=O)C(=O)NC(CC(O)=O)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)N2)C(C)O)=O)NC(=O)C(C(C)O)NC(=O)C(N)CSSC1)CC1=CN=CN1 LXPHPKVWHQLBBA-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- OZIWEYQVUCTOIU-UHFFFAOYSA-K sodium;trichlororuthenium Chemical compound [Na].Cl[Ru](Cl)Cl OZIWEYQVUCTOIU-UHFFFAOYSA-K 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000005302 thiazolylmethyl group Chemical group [H]C1=C([H])N=C(S1)C([H])([H])* 0.000 description 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- FKKJJPMGAWGYPN-UHFFFAOYSA-N thiophen-2-ylmethanamine Chemical compound NCC1=CC=CS1 FKKJJPMGAWGYPN-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical compound I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 1
- 125000001680 trimethoxyphenyl group Chemical group 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32732994 | 1994-12-28 | ||
JP16945495 | 1995-07-05 | ||
PCT/JP1995/002605 WO1996020177A1 (fr) | 1994-12-28 | 1995-12-19 | Derives pyrimidiniques |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973001D0 NO973001D0 (no) | 1997-06-27 |
NO973001L true NO973001L (no) | 1997-08-27 |
Family
ID=26492784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973001A NO973001L (no) | 1994-12-28 | 1997-06-27 | Pyrimidin-derivater |
Country Status (12)
Country | Link |
---|---|
US (2) | US6008224A (fi) |
EP (1) | EP0801062B1 (fi) |
CN (1) | CN1171785A (fi) |
AT (1) | ATE238285T1 (fi) |
CA (1) | CA2207100C (fi) |
DE (1) | DE69530516T2 (fi) |
ES (1) | ES2196090T3 (fi) |
FI (1) | FI972795A0 (fi) |
HU (1) | HUT77534A (fi) |
NO (1) | NO973001L (fi) |
PT (1) | PT801062E (fi) |
WO (1) | WO1996020177A1 (fi) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP9903526A3 (en) * | 1995-09-06 | 2000-07-28 | Kowa Co | Pyrimidine derivatives and pharmaceutical compositions containing the same |
US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
ATE316963T1 (de) * | 2000-01-25 | 2006-02-15 | Hoffmann La Roche | Herstellung von sulfonamiden |
US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
US11446303B2 (en) * | 2019-06-21 | 2022-09-20 | Tosk, Inc. | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
HUP9903526A3 (en) * | 1995-09-06 | 2000-07-28 | Kowa Co | Pyrimidine derivatives and pharmaceutical compositions containing the same |
-
1995
- 1995-12-19 CA CA002207100A patent/CA2207100C/en not_active Expired - Fee Related
- 1995-12-19 DE DE69530516T patent/DE69530516T2/de not_active Expired - Fee Related
- 1995-12-19 PT PT95940471T patent/PT801062E/pt unknown
- 1995-12-19 EP EP95940471A patent/EP0801062B1/en not_active Expired - Lifetime
- 1995-12-19 CN CN95197129.8A patent/CN1171785A/zh active Pending
- 1995-12-19 ES ES95940471T patent/ES2196090T3/es not_active Expired - Lifetime
- 1995-12-19 HU HU9800062A patent/HUT77534A/hu unknown
- 1995-12-19 AT AT95940471T patent/ATE238285T1/de not_active IP Right Cessation
- 1995-12-19 US US08/849,725 patent/US6008224A/en not_active Expired - Fee Related
- 1995-12-19 WO PCT/JP1995/002605 patent/WO1996020177A1/ja active IP Right Grant
-
1997
- 1997-06-27 NO NO973001A patent/NO973001L/no unknown
- 1997-06-27 FI FI972795A patent/FI972795A0/fi unknown
-
1999
- 1999-11-05 US US09/434,474 patent/US6337334B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO973001D0 (no) | 1997-06-27 |
PT801062E (pt) | 2003-08-29 |
DE69530516D1 (de) | 2003-05-28 |
AU4190096A (en) | 1996-07-19 |
EP0801062A1 (en) | 1997-10-15 |
EP0801062B1 (en) | 2003-04-23 |
EP0801062A4 (en) | 1998-04-29 |
DE69530516T2 (de) | 2003-12-24 |
WO1996020177A1 (fr) | 1996-07-04 |
ES2196090T3 (es) | 2003-12-16 |
ATE238285T1 (de) | 2003-05-15 |
US6337334B1 (en) | 2002-01-08 |
CN1171785A (zh) | 1998-01-28 |
FI972795A (fi) | 1997-06-27 |
FI972795A0 (fi) | 1997-06-27 |
CA2207100C (en) | 2008-02-19 |
US6008224A (en) | 1999-12-28 |
HUT77534A (hu) | 1998-05-28 |
AU696216B2 (en) | 1998-09-03 |
CA2207100A1 (en) | 1996-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003297398B2 (en) | Asthma and allergic inflammation modulators | |
AU2003276802B2 (en) | 2-pyridone derivatives as inhibitors of neutrophile elastase | |
AU2006335967B2 (en) | Novel heterocycles | |
JP5828201B2 (ja) | ナフタレン誘導体 | |
US20070082912A1 (en) | Pyrrole compounds for the treatment of prostaglandine mediated diseases | |
JPH11512399A (ja) | ピリミジンカルボキサミドおよび関連化合物ならびに炎症状態を処置するための方法 | |
JPH10509182A (ja) | 新規なスルホンアミド類 | |
TW200911245A (en) | Pyridone derivatives | |
EP1542978B1 (en) | Novel bio-active molecules | |
US20060247261A1 (en) | Pyrimidine compounds | |
US6337334B1 (en) | Pyrimidine derivatives | |
JP2790926B2 (ja) | スルホンアミド誘導体 | |
AU2009208712A1 (en) | Novel heterocycles | |
US7365069B2 (en) | Pyrimidone derivatives | |
JP3734870B2 (ja) | ピリミジン誘導体及びこれを含有する医薬 | |
JP3728028B2 (ja) | ピリミジン誘導体 |